British Pharmacopoeia 2023, BP 2023
New, legally enforced standards, available from 1 August 2022. All European Pharmacopoeia texts included.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
New for the BP 2023
The BP 2023 supersedes the BP 2022 and becomes legally effective on 1 January 2023. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
Monographs and content:
- 23 new BP monographs, 59 new Ph. Eur. monographs.
- 151 amended BP monographs.
- All monographs from the Ph. Eur. 10th edition as amended by Supplements 10.1 to 10.8 are included.
- Ph. Eur. supplements 11.0, 11.1, and 11.2 included as in-year online and download product updates.
Ensure you get the best value access to the information you need. Choose from a range of flexible licences and formats - including full online and offline access.